MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

A Culture of Creativity

This year's featured leaders illustrate medtech's ability to adapt and thrive in an ever-changing business environment.


Return to article:

At Covidien Ltd. (Hamilton, Bermuda), one of the company's key strategic initiatives is its commitment to innovation. As a newly independent healthcare company, Covidien is committed to de­livering superior new products to address unmet needs, and to innovate for better patient outcomes.

Research and development spending has more than doubled in the past five years, with more than a 30% increase reported in fiscal 2008. The company has stated that its goal is to spend 4–5% of sales on R&D within the next several years, up from less than 2% five years ago.

(click to enlarge)
Latest offerings in the Sandman line of continuous positive airway pressure devices by Covidien.

Covidien launched more than 30 new products in 2008, with key new products in each of its four business segments. These innovative offerings included the following.

  • A unique imaging injector with RFID technology.
  • Three continuous positive airway pressure (CPAP) devices in the respiratory business.
  • Several mesh products and a unique absorbable tacker used in hernia repair.
  • New instruments for use in electrosurgery, including LigaSure Impact and Advance.
  • Generic versions of oxycodone extended-release tablets and sestamibi.
Copyright ©2008 MX
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.